TRANSGENIC STUDIES OF LEUKOCYTE CD11A PROMOTER
白细胞CD11A启动子的转基因研究
基本信息
- 批准号:2734911
- 负责人:
- 金额:$ 8.37万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1994
- 资助国家:美国
- 起止时间:1994-07-01 至 2000-06-30
- 项目状态:已结题
- 来源:
- 关键词:B lymphocyte CD antigens cell differentiation flow cytometry gene expression genetic promoter element genetic regulation genetically modified animals human genetic material tag integrins laboratory mouse leukocyte adhesion molecules macrophage messenger RNA monocyte northern blottings polymerase chain reaction protein structure reporter genes tissue /cell culture
项目摘要
This proposal aims to use the leukocyte integrin CD11a (leukocyte function
antigen-1, LFA-1) promoter to direct tissue and stage specific expression
of reporter genes in transgenic mice. The integrin gene family codes for
heterodimers which mediate cell to cell and cell to matrix adherence. CDI
Ia belongs to the beta-2 subclass, or leukocyte, integrins, which mediate
cellular adherence in inflammation and the immune response. Leukocyte
integrins are responsible for leukocyte margination and emigration into
inflamed tissues, and function as co-receptors in tumor and microbial
killing and T-cell activation. The leukocyte integrin molecules consist of
one of three alpha chains (CD11a, CD11b, or CD11c) noncovalently bound to
a single common beta chain (CD18) to form three different heterodimers.
Although CD18 is expressed on all leukocytes, CD11a is expressed on T and
B lymphocytes, monocytes, and macrophages. The leukocyte integrins are
also differentially expressed in leukocyte ontogeny, showing, in general,
increased expression with leukocyte maturation, differentiation, and
activation. In vitro transfection studies of CD11a-promoter -human growth
hormone reporter gene constructs have defined regions of the CD11a
promoter responsible for high level, tissue specific expression.The
experiments described in this proposal will investigate the regulation of
the CD11a promoter in transgenic mice. A construct consisting of 0.8
kilobases of the human CD11a promoter driving a human CD4-human growth
hormone minigene is currently being injected into mouse oocytes. The
cytoplasmic portion of the CD4 gene has been deleted to reduce the
possibility of intracellular signalling via associated protein kinases so
that CD4 may serve only as a cell surface reporter molecule. Initial
experiments will detect the integrated transgene and characterize its
expression. Lineage specific expression on leukocytes will be assayed by
FACS analysis of peripheral blood and lymph node leukocytes . Tissue
specific expression will be further characterized by screening various
tissues for transgene mRNA using RNA blots and a reverse transcriptase-PCR
assay. Additional regulatory sequences will be delineated by injecting
other constructs having additional 5', intronic, and 3' sequences from the
human CD11a gene . This approach, plus a comparison with parallel
transgenic studies using the human CD11b and CD18 promoters should
delineate regulatory regions responsible for differential gene expression
in lymphocytes and monocytes/macrophages and provide insight into the
sequences responsible for coordinate regulation of the CD11 and CD18
subunits during hematopoietic cell differentiation. Long-term plans
involve using the CD11a promoter to: 1) express inducible cellular toxins
in leukocytes to create an animal model in which to study the role of
leukocytes in inflammation; and 2) express selected oncogenes in
leukocytes to study the differentiation of B cells and
monocytes/macrophages. In sum, these experiments will investigate the
regulation of a)11a, an important leukocyte adherence molecule, and use
the CD11a promoter in transgenic mice to study leukocyte function and
ontogeny.
该建议旨在使用白细胞整合蛋白CD11A(白细胞功能
抗原1,LFA-1)启动子直接组织和分期特定表达
转基因小鼠中的报告基因。整合素基因家族代码
异二聚体,将细胞介导细胞和细胞的基质粘附。 CDI
ia属于介导的Beta-2子类或白细胞的整合素
炎症和免疫反应中的细胞粘附。白细胞
整联蛋白负责白细胞边缘和移民到
发炎的组织,并充当肿瘤和微生物的共受体
杀死和T细胞激活。白细胞整联蛋白分子由
三个α链(CD11A,CD11B或CD11C)中的三个无共价结合
单个常见的β链(CD18)形成三种不同的异二聚体。
尽管CD18在所有白细胞上表达,但CD11a在T和
B淋巴细胞,单核细胞和巨噬细胞。白细胞结构是
在白细胞个体发育中也差异表达,通常显示
通过白细胞成熟,分化和
激活。 CD11A促进剂 - 人类生长的体外转染研究
激素报告基因构建体已定义了CD11a的区域
负责高水平,组织特异性表达的启动子。
本提案中描述的实验将调查调节
转基因小鼠中的CD11a启动子。由0.8组成的构造
人类CD11a启动子的千目标驱动人类CD4-Human生长
当前,荷尔蒙微型基因被注射到小鼠卵母细胞中。这
CD4基因的细胞质部分已被删除以减少
通过相关蛋白激酶的细胞内信号传导的可能性
该CD4只能用作细胞表面报告基因分子。最初的
实验将检测到集成的转基因并表征其
表达。白细胞上的谱系特定表达将由
外周血和淋巴结白细胞的FACS分析。组织
特定表达将通过筛选各种表达来进一步表征
使用RNA印迹和逆转录酶-PCR的转基因mRNA组织
测定。将通过注射来划定其他调节序列
其他具有额外5',内含子和3'序列的构造
人CD11a基因。这种方法,以及与平行的比较
使用人CD11b和CD18启动子的转基因研究应
划定负责差异基因表达的调节区域
在淋巴细胞和单核细胞/巨噬细胞中,并洞悉
负责坐标CD11和CD18的序列
造血细胞分化过程中的亚基。长期计划
涉及使用CD11a启动子:1)表达可诱导的细胞毒素
在白细胞中创建一个动物模型,以研究其作用
炎症中的白细胞; 2)在
白细胞研究B细胞和
单核细胞/巨噬细胞。总而言之,这些实验将研究
调节A)11a,一个重要的白细胞依从性分子,并使用
转基因小鼠中的CD11a启动子研究白细胞功能和
个体发育。
项目成果
期刊论文数量(2)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Immobilized anti-CD3 antibody activates T cell clones to induce the production of interstitial collagenase, but not tissue inhibitor of metalloproteinases, in monocytic THP-1 cells and dermal fibroblasts.
固定化抗 CD3 抗体可激活 T 细胞克隆,诱导单核 THP-1 细胞和真皮成纤维细胞中间质胶原酶的产生,但不产生金属蛋白酶的组织抑制剂。
- DOI:
- 发表时间:1995
- 期刊:
- 影响因子:0
- 作者:Miltenburg,AM;Lacraz,S;Welgus,HG;Dayer,JM
- 通讯作者:Dayer,JM
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
KINDRED A RITCHIE其他文献
KINDRED A RITCHIE的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('KINDRED A RITCHIE', 18)}}的其他基金
TRANSGENIC STUDIES OF LEUKOCYTE CD11A PROMOTER
白细胞CD11A启动子的转基因研究
- 批准号:
2210847 - 财政年份:1994
- 资助金额:
$ 8.37万 - 项目类别:
TRANSGENIC STUDIES OF LEUKOCYTE CD11A PROMOTER
白细胞CD11A启动子的转基因研究
- 批准号:
2210845 - 财政年份:1994
- 资助金额:
$ 8.37万 - 项目类别:
TRANSGENIC STUDIES OF LEUKOCYTE CD11A PROMOTER
白细胞CD11A启动子的转基因研究
- 批准号:
2444985 - 财政年份:1994
- 资助金额:
$ 8.37万 - 项目类别:
TRANSGENIC STUDIES OF LEUKOCYTE CD11A PROMOTER
白细胞CD11A启动子的转基因研究
- 批准号:
2210846 - 财政年份:1994
- 资助金额:
$ 8.37万 - 项目类别:
HLA CLASS II REGULATOR GENE CLONING BY RETROVIRAL TAGS
通过逆转录病毒标签克隆 HLA II 类调节基因
- 批准号:
3030210 - 财政年份:1990
- 资助金额:
$ 8.37万 - 项目类别:
HLA CLASS II REGULATOR GENE CLONING BY RETROVIRAL TAGS
通过逆转录病毒标签克隆 HLA II 类调节基因
- 批准号:
3030209 - 财政年份:1989
- 资助金额:
$ 8.37万 - 项目类别:
相似国自然基金
高危HPV抗原特异性三级淋巴结构诱导CD4T细胞分化增强抗肿瘤免疫的作用机制研究
- 批准号:
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
高危HPV抗原特异性三级淋巴结构诱导CD4T细胞分化增强抗肿瘤免疫的作用机制研究
- 批准号:82203512
- 批准年份:2022
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目
结核病患者抗原特异性CD4+T细胞分化及功能异常的分子机制研究
- 批准号:81201258
- 批准年份:2012
- 资助金额:23.0 万元
- 项目类别:青年科学基金项目
六味地黄丸诱导负载胃癌干细胞抗原的DC分化及其对CD4+CD25+调节性T细胞作用的研究
- 批准号:81273980
- 批准年份:2012
- 资助金额:70.0 万元
- 项目类别:面上项目
CD40L对人工自身核抗原hLa的自身反应性B细胞的发育和分化的影响
- 批准号:81072412
- 批准年份:2010
- 资助金额:10.0 万元
- 项目类别:面上项目
相似海外基金
Co-stimuli for Human Marginal Zone B Cell Activation
人类边缘区 B 细胞激活的共刺激
- 批准号:
6764031 - 财政年份:2002
- 资助金额:
$ 8.37万 - 项目类别:
Co-stimuli for Human Marginal Zone B Cell Activation
人类边缘区 B 细胞激活的共刺激
- 批准号:
6508161 - 财政年份:2002
- 资助金额:
$ 8.37万 - 项目类别:
Co-stimuli for Human Marginal Zone B Cell Activation
人类边缘区 B 细胞激活的共刺激
- 批准号:
6629463 - 财政年份:2002
- 资助金额:
$ 8.37万 - 项目类别:
Generation of antigen-specific regulation T cells
抗原特异性调节 T 细胞的产生
- 批准号:
6558064 - 财政年份:2002
- 资助金额:
$ 8.37万 - 项目类别:
Human B Cell Differentiation in a Model System
模型系统中的人类 B 细胞分化
- 批准号:
6398139 - 财政年份:2001
- 资助金额:
$ 8.37万 - 项目类别: